Norway· NO-ID_96FACFB7-E32C-4CD8-B28F-2A5AA525CDE1
Dupixent
A dupilumab product containing dupilumab, registered in Norway by Sanofi Winthrop Industrie. The same ATC class is registered in 16 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Dupilumab is registered in 16 of 19 countries.
Countries holding a registration under ATC D11AH05 (dupilumab), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 10 of them publish a price we can compare per daily dose
Dupilumab · ATC D11AH05
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of dupilumab costs, country by country.
Normalised to the WHO defined daily dose (21.4 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Dupilumab · price per daily dose (21.4 mg)
USD · FX 28 Sept 2026
- CH Switzerland$72.07
The record
At a glance
FEST (Norway)- Active substance
- Dupilumab
- Manufacturer
- Sanofi Winthrop Industrie
- Country
- Norway (NO)
- ATC code
- D11AH05
- ATC class
- Dupilumab
- Defined daily dose
- 21.4 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 5
1 priced- no_merkevare_idID_96FACFB7-E32C-4CD8-B28F-2A5AA525CDE1
- no_varenummer5821512 x 2NOK 15378.9
- gtin3664798063431
- no_varenummer471531
- gtin3664798035247
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
56 interactions on record for dupilumab.
Graded by severity as the source publishes them — 27 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dupilumab · interactions on record
56 records
- 27 severe
- 22 moderate
- 7 minor
Most severe, free to view
- CladribineL01BB04severe
- Talimogene laherparepvecL01XL02severe
- Talimogen laherparepvecL01XX51severe
- LeflunomidL04AA13severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dupilumab in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDUPIXENTSanofi Winthrop Industrie, Gentilly
- BelgiumDupixent 300 mgSanofi Winthrop Industrie
- SpainDUPIXENT 300 MG SOLUCION INYECTABLE EN JERINGA PRECARGADASanofi Winthrop Industrie
- IcelandDupixentSanofi Winthrop Industrie
- SwedenDupixent 300 mg Injektionsvätska, lösning i förfylld injektionspennaSanofi Winthrop Industrie
- United StatesDupixentSanofi-Aventis U.S. LLC
- ItalyDUPIXENT*1 penna preriempita SC 200 mg 1,14 mlSANOFI WINTHROP INDUSTRIE
- FinlandDupixentSanofi Winthrop Industrie
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Dupixent
- Iceland · Dupixent
- Liechtenstein · Dupixent
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f84d24f3-3672-42ff-b707-d9d7cb5d5ef3 GET /v1/drugs/f84d24f3-3672-42ff-b707-d9d7cb5d5ef3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Injeksjonsvæske, oppløsning i ferdigfylt penn",
"source": "fest",
"status": "A",
"atc_name": "Dupilumab",
"merkevare_id": "ID_96FACFB7-E32C-4CD8-B28F-2A5AA525CDE1",
"name_form_strength": "Dupixent inj, oppl 300 mg/penn",
"prescription_group": "C"
}See everything about dupilumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.